Physician profile
Scott Zenoni
NPI 1316287345
$21,645.21
in general payments reported to CMS, 2019-2025
9 companies · $6,163 in 2025
The $6,163 reported for 2025 was more than what 91% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,418 · 2020: $9,123 · 2021: $10.37 · 2022: $104 · 2023: $793 · 2024: $33.90 · 2025: $6,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,020 · Travel and Lodging: $2,629 · Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,020.00 |
| Travel and Lodging | $2,629.21 |
| Food and Beverage | $340.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,635.52 | 2019-2025 | |
| Medical Device Business Services, INC. | $664.71 | 2023 | Matrixrib |
| Heron Therapeutics, INC. | $128.06 | 2023 | Zynrelef |
| Kci USA, INC. | $125.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $27.65 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.12 | 2020 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Avanos Medical | $13.78 | 2019 | |
| Kls-Martin L.P. | $10.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Zenoni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.